• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膀胱疼痛综合征患者膀胱镜检查发现的局灶性和弥漫性血管增多对预测膀胱内治疗反应的影响

Effect of focal and diffuse hypervascularization as cystoscopic findings on predicting intravesical therapy response in patients with bladder pain syndrome.

作者信息

Erol Bulent, Kazan Huseyin Ozgur, Keser Ferhat, Efiloglu Ozgur, Danacıoğlu Yavuz Onur, Onur Rahmi

机构信息

Department of Urology, İstanbul Medeniyet University School of Medicine, İstanbul, Turkey.

Department of Urology, BakırkÖy Dr. Sadi Konuk Training and Research Hospital, İstanbul, Turkey.

出版信息

Turk J Urol. 2021 Jul;47(4):325-337. doi: 10.5152/tju.2021.21093.

DOI:10.5152/tju.2021.21093
PMID:35118960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9612766/
Abstract

OBJECTIVE

To define the relationship between cystoscopic findings, including novel findings such as the hypervascularization, of bladder pain syndrome/interstitial cystitis (BPS/IC) and the response to intravesical therapy.

MATERIAL AND METHODS

We retrospectively evaluated cystoscopy findings in patients who had a preliminary diagnosis of BPS/IC. All patients received early intravesical combined therapy (ICT), ie, within 2 hours after hydrodistention. Additionally, ICT was continued according to our protocol. Cystoscopic findings were classified as glomerulations, hypervascularization, and Hunner's lesion (HL). The therapy responses were evaluated at 1st, 3rd, 6th, and 12thmonths using the visual analog scale (VAS), O'Leary/Sant interstitial cystitis symptom index (ICSI), and interstitial cystitis problem index (ICPI) scores.

RESULTS

Out of 61 patients, HL was diagnosed during cystoscopy in six (9.8%) patients, glomerulations in 35 (57.4%) patients, and hypervascularization in 15 (24.6%) patients. No pathological findings were defined in five (8.2%) patients. In the glomerulation and hypervascularization group, the median VAS, ICSI, and ICPI scores were lower than those in the preoperative period in the follow-up. In patients with HL, the median VAS scores were lower in the entire follow-up compared to the preoperative period, with an increase at 1st year compared to 6th month, and ICSI scores were lower than preoperative period in the entire follow-up, with an increase at 3rd month and 1st year. ICPI scores were also lower during the follow-up, with an increase observed in the 1st year.

CONCLUSION

The presence of hypervascularization should be defined since it might show different characteristics that may affect the ICT response. Patients with glomerulations might be good candidates for early combined intravesical therapy.

摘要

目的

明确膀胱疼痛综合征/间质性膀胱炎(BPS/IC)的膀胱镜检查结果,包括如血管增生等新发现,与膀胱内治疗反应之间的关系。

材料与方法

我们回顾性评估了初步诊断为BPS/IC的患者的膀胱镜检查结果。所有患者均接受早期膀胱内联合治疗(ICT),即在膀胱扩张术后2小时内进行。此外,ICT按照我们的方案持续进行。膀胱镜检查结果分为点状出血、血管增生和Hunner病变(HL)。使用视觉模拟量表(VAS)、O'Leary/Sant间质性膀胱炎症状指数(ICSI)和间质性膀胱炎问题指数(ICPI)评分在第1、3、6和12个月评估治疗反应。

结果

61例患者中,膀胱镜检查诊断为HL的有6例(9.8%),点状出血的有35例(57.4%),血管增生的有15例(24.6%)。5例(8.2%)患者未发现病理结果。在点状出血和血管增生组中,随访期间VAS、ICSI和ICPI评分的中位数低于术前。HL患者在整个随访期间VAS评分中位数低于术前,与第6个月相比,第1年有所增加;ICSI评分在整个随访期间低于术前,在第3个月和第1年有所增加。随访期间ICPI评分也较低,第1年有所增加。

结论

应明确血管增生的存在,因为它可能表现出不同的特征,可能影响ICT反应。点状出血的患者可能是早期膀胱内联合治疗的良好候选者。

相似文献

1
Effect of focal and diffuse hypervascularization as cystoscopic findings on predicting intravesical therapy response in patients with bladder pain syndrome.膀胱疼痛综合征患者膀胱镜检查发现的局灶性和弥漫性血管增多对预测膀胱内治疗反应的影响
Turk J Urol. 2021 Jul;47(4):325-337. doi: 10.5152/tju.2021.21093.
2
Cystoscopic characteristic findings of interstitial cystitis and clinical implications.间质性膀胱炎的膀胱镜特征性表现及临床意义。
Tzu Chi Med J. 2023 Aug 22;36(1):30-37. doi: 10.4103/tcmj.tcmj_172_23. eCollection 2024 Jan-Mar.
3
[Treatment of intravesical instillation with fulguration-hydrodistention on female interstitial cystitis].[电灼-膀胱扩张术膀胱内灌注治疗女性间质性膀胱炎]
Beijing Da Xue Xue Bao Yi Xue Ban. 2023 Oct 18;55(5):865-870. doi: 10.19723/j.issn.1671-167X.2023.05.014.
4
Does repeated hydrodistension with transurethral fulguration for interstitial cystitis with Hunner's lesion cause bladder contraction?经尿道电灼联合反复膀胱水扩张治疗间质性膀胱炎(Hunner溃疡型)是否会导致膀胱挛缩?
Arab J Urol. 2019 Apr 8;17(1):77-81. doi: 10.1080/2090598X.2019.1589753. eCollection 2019 Mar.
5
Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.经尿道重复注射肉毒毒素 A 治疗难治性间质性膀胱炎/膀胱疼痛综合征有效。
Int J Clin Pract. 2013 May;67(5):427-34. doi: 10.1111/ijcp.12113.
6
Clinical characterization of interstitial cystitis/bladder pain syndrome in women based on the presence or absence of Hunner lesions and glomerulations.基于是否存在Hunner病变和膀胱黏膜下出血点对女性间质性膀胱炎/膀胱疼痛综合征的临床特征分析
Low Urin Tract Symptoms. 2021 Jan;13(1):139-143. doi: 10.1111/luts.12344. Epub 2020 Aug 23.
7
Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.膀胱内注射肉毒毒素 A 对溃疡型间质性膀胱炎患者无益。
Pain Physician. 2013 Mar-Apr;16(2):109-16.
8
The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.膀胱内透明质酸治疗对间质性膀胱炎/膀胱疼痛综合征女性患者尿动力学和临床结局的影响。
Taiwan J Obstet Gynecol. 2020 Nov;59(6):922-926. doi: 10.1016/j.tjog.2020.09.021.
9
Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment.膀胱镜下液压扩张特征为治疗后间质性膀胱炎的临床和长期预后特征提供了依据。
Sci Rep. 2021 Jan 11;11(1):455. doi: 10.1038/s41598-020-80252-x.
10
Reliability and validity of Turkish versions of the interstitial cystitis symptom index and interstitial cystitis problem index.土耳其语版间质性膀胱炎症状指数和间质性膀胱炎问题指数的信度和效度。
Neurourol Urodyn. 2020 Nov;39(8):2338-2343. doi: 10.1002/nau.24492. Epub 2020 Aug 26.

引用本文的文献

1
Cystoscopic characteristic findings of interstitial cystitis and clinical implications.间质性膀胱炎的膀胱镜特征性表现及临床意义。
Tzu Chi Med J. 2023 Aug 22;36(1):30-37. doi: 10.4103/tcmj.tcmj_172_23. eCollection 2024 Jan-Mar.
2
Efficacy of intravesical cocktail therapy with or without dimethyl sulphoxide in interstitial cystitis.膀胱内联合或不联合二甲基亚砜鸡尾酒疗法治疗间质性膀胱炎的疗效
Cent European J Urol. 2022;75(3):299-304. doi: 10.5173/ceju.2022.129. Epub 2022 Sep 24.

本文引用的文献

1
Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome.在间质性膀胱炎/膀胱疼痛综合征患者中,膀胱组织中的血管生成与尿频和膀胱疼痛强烈相关。
Int J Urol. 2019 Jun;26 Suppl 1:35-40. doi: 10.1111/iju.13972.
2
Safety and efficacy of Intravesical hyaluronic acid/chondroitin sulfate in the treatment of refractory painful bladder syndrome.膀胱内注射透明质酸/硫酸软骨素治疗难治性疼痛性膀胱综合征的安全性和有效性。
Turk J Urol. 2018 Nov 21;45(4):296-301. doi: 10.5152/tud.2018.63600. Print 2019 Jul.
3
A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis.一项关于膀胱疼痛综合征/间质性膀胱炎女性患者膀胱内注射透明质酸和硫酸软骨素与二甲亚砜疗效及安全性的随机、开放标签、多中心研究。
Neurourol Urodyn. 2017 Apr;36(4):1178-1186. doi: 10.1002/nau.23091. Epub 2016 Sep 21.
4
A standard for terminology in chronic pelvic pain syndromes: A report from the chronic pelvic pain working group of the international continence society.慢性盆腔疼痛综合征术语标准:国际尿控协会慢性盆腔疼痛工作组报告
Neurourol Urodyn. 2017 Apr;36(4):984-1008. doi: 10.1002/nau.23072. Epub 2016 Aug 26.
5
Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: A Relook at the Role of Cystoscopy.临床表型不能区分 Hunner 病变型间质性膀胱炎/膀胱疼痛综合征:重新审视膀胱镜的作用。
J Urol. 2016 Oct;196(4):1136-40. doi: 10.1016/j.juro.2016.04.067. Epub 2016 Apr 23.
6
Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment.间质性膀胱炎/膀胱疼痛综合征的诊断与治疗:美国泌尿外科学会指南修订案
J Urol. 2015 May;193(5):1545-53. doi: 10.1016/j.juro.2015.01.086. Epub 2015 Jan 23.
7
Down regulation of vascular endothelial growth factor is associated with decreased inflammation after intravesical OnabotulinumtoxinA injections combined with hydrodistention for patients with interstitial cystitis--clinical results and immunohistochemistry analysis.经膀胱注射肉毒毒素 A 联合水扩张治疗间质性膀胱炎患者后,血管内皮生长因子下调与炎症减轻相关——临床结果和免疫组化分析。
Urology. 2013 Dec;82(6):1452.e1-6. doi: 10.1016/j.urology.2013.09.003.
8
Validation of voiding diary for stratification of bladder pain syndrome according to the presence/absence of cystoscopic abnormalities: a two-centre prospective study.根据膀胱镜异常的存在/缺失情况对膀胱疼痛综合征进行分层的排尿日记的验证:一项两中心前瞻性研究。
BJU Int. 2013 Jul;112(2):E164-8. doi: 10.1111/bju.12165.
9
Clinical characteristics differ considerably between phenotypes of bladder pain syndrome/interstitial cystitis.膀胱疼痛综合征/间质性膀胱炎各表型之间的临床特征差异很大。
Scand J Urol Nephrol. 2012 Oct;46(5):365-70. doi: 10.3109/00365599.2012.689008. Epub 2012 May 21.
10
Diagnosis of interstitial cystitis/bladder pain syndrome in women with chronic pelvic pain: a prospective observational study.慢性盆腔疼痛女性间质性膀胱炎/膀胱疼痛综合征的诊断:一项前瞻性观察研究。
Int Urogynecol J. 2012 Oct;23(10):1361-6. doi: 10.1007/s00192-012-1711-5. Epub 2012 Mar 8.